Apparatus and method for performing HARQ transmission in a wireless communication system
    3.
    发明申请
    Apparatus and method for performing HARQ transmission in a wireless communication system 有权
    在无线通信系统中执行HARQ传输的装置和方法

    公开(公告)号:US20070245203A1

    公开(公告)日:2007-10-18

    申请号:US11728420

    申请日:2007-03-26

    IPC分类号: H04L1/18 G08C25/02

    摘要: An apparatus and method for optimizing a data rate in a wireless communication system supporting Hybrid Automatic Repeat reQuest (HARQ) are provided. The method includes estimating Channel State Information (CSI) of a signal to be transmitted, by using other CSIs received in a previous cycle; determining an instantaneous data rate, at which the CSI is transmitted with an optimal data rate, and the amount of redundancy information to be retransmitted; and retransmitting the redundancy information of the signal according to the amount of redundancy information and the instantaneous data rate, if a receiving end requests signal retransmission. Accordingly, the packet can be transmitted with the optimal data rate.

    摘要翻译: 提供了一种用于在支持混合自动重传请求(HARQ)的无线通信系统中优化数据速率的装置和方法。 该方法包括通过使用在前一周期中接收的其它CSI来估计要发送的信号的信道状态信息(CSI); 确定以最佳数据速率发送CSI的瞬时数据速率和要重传的冗余信息量; 并且如果接收端请求信号重传,则根据冗余信息量和瞬时数据速率重发信号的冗余信息。 因此,可以以最佳数据速率发送分组。

    Pharmaceutical composition for prevention and treatment of drug or alcohol addiction or bipolar disorder using sodium phenylbutyrate
    6.
    发明授权
    Pharmaceutical composition for prevention and treatment of drug or alcohol addiction or bipolar disorder using sodium phenylbutyrate 有权
    使用苯丁酸钠预防和治疗药物或酒精成瘾或双相情感障碍的药物组合物

    公开(公告)号:US07968604B2

    公开(公告)日:2011-06-28

    申请号:US11992211

    申请日:2006-08-30

    IPC分类号: A61K31/12

    摘要: Provided is a pharmaceutical composition for prevention and treatment of drug or alcohol addiction or bipolar disorder, comprising sodium phenylbutyrate (PBA). The pharmaceutical composition for prevention and treatment of drug or alcohol addiction or bipolar disorder in accordance with the present invention provides effects capable of inhibiting increases in locomotor activity which is a behavioral indicator of drug or alcohol addiction or bipolar disorder, by controlling a level of a neurotransmitter via regulation of expression of a neurotransmitter transporter.

    摘要翻译: 提供了用于预防和治疗药物或酒精成瘾或双相性精神障碍的药物组合物,其包含苯丁酸钠(PBA)。 根据本发明的用于预防和治疗药物或酒精成瘾或双相性精神障碍的药物组合物提供了能够抑制作为药物或酒精成瘾或双相情感障碍的行为指标的运动活性增加的效果,通过控制 神经递质通过调节神经递质转运蛋白的表达。

    Pharmaceutical Composition for Prevention and Treatment of Drug or Alcohol Addiction or Bipolar Disorder Using Sodium Phenylbutyrate
    7.
    发明申请
    Pharmaceutical Composition for Prevention and Treatment of Drug or Alcohol Addiction or Bipolar Disorder Using Sodium Phenylbutyrate 有权
    使用苯丁酸钠预防和治疗药物或酒精成瘾或双相障碍的药物组合物

    公开(公告)号:US20090221714A1

    公开(公告)日:2009-09-03

    申请号:US11992211

    申请日:2006-08-30

    IPC分类号: A61K31/12 A61P25/36

    摘要: Provided is a pharmaceutical composition for prevention and treatment of drug or alcohol addiction or bipolar disorder, comprising sodium phenylbutyrate (PBA). The pharmaceutical composition for prevention and treatment of drug or alcohol addiction or bipolar disorder in accordance with the present invention provides effects capable of inhibiting increases in locomotor activity which is a behavioral indicator of drug or alcohol addiction or bipolar disorder, by controlling a level of a neurotransmitter via regulation of expression of a neurotransmitter transporter.

    摘要翻译: 提供了用于预防和治疗药物或酒精成瘾或双相性精神障碍的药物组合物,其包含苯丁酸钠(PBA)。 根据本发明的用于预防和治疗药物或酒精成瘾或双相性精神障碍的药物组合物提供了能够抑制作为药物或酒精成瘾或双相情感障碍的行为指标的运动活性增加的效果,通过控制 神经递质通过调节神经递质转运蛋白的表达。